Wanquan Pharmaceutical Group (Hainan) is a pioneer among China's technology-based pharmaceutical enterprises and is becoming a leading provider of new drug technology products and sales market services in China. The company is an international conglomerate, a pioneer in China's technology-based pharmaceutical industry, and a leading provider of new drug technology products and sales market services. It is an international conglomerate listed in Hong Kong (8225), with shareholders including overseas Wanquan Pharmaceutical Holdings, Yoken Life, and the C-Tech fund managed by Shanghai Lianchuang, which is composed of Singapore's Government Investment Corporation (GIC), Nomura Securities (Jafco), Kerry, and K.WAH. The group has been rated by the authoritative international business magazine Fortune (Chinese edition) as one of the five most promising development companies in China. Wanquan's goal: with new drug development as its core competitiveness, fully leverage current industry opportunities, integrate resources from all parties, and jointly create a highly respected leading pharmaceutical enterprise for the Chinese nation. Hainan Wanquan Life Park - We have a dream: to select a favorable location, gather a group of industry elites, and lead the wave of the biomedical economy era with great courage and insight; we have a dream: with strong government support, to build Hainan Island into a "strategic highland for the Chinese nation to win in the international pharmaceutical arena." The composition of the "Industry-University-Research" consortium: 1. Hainan Shengke Life Science Research Institute - Wanquan Hainan Shengke Life Science Research Institute is an international pharmaceutical enterprise founded by a group of drug experts and pharmaceutical industry management experts with North American backgrounds, focusing on new drug research and development as well as pharmaceutical technology services. Its founders have all worked in multinational pharmaceutical companies and research institutions, with extensive experience in technology, management, and sales and marketing. Leveraging overseas advantages in technology, management, and capital, Shengke Life Science Research Institute will build the Hainan Research Institute into the largest innovative drug research base in southern China with the best experimental and living facilities. 2. Wante Pharmaceutical (Hainan) Co., Ltd. - Wante Pharmaceutical (Hainan) Co., Ltd. is one of China's first export-oriented pharmaceutical processing bases in the Hainan International Pharmaceutical Valley that complies with U.S. GMP standards, established by Wanquan Technology Pharmaceutical. It will gradually develop into the largest drug export base in the Far East, generating annual marketing revenue of 7-10 billion yuan. It is a pillar component of the Hainan Pharmaceutical Valley.
What does Wante Pharmaceutical (Hainan) Co., Ltd. require? Who is Wante Pharmaceutical (Hainan) Co., Ltd. hiring? recruitment: 经营管理类占比最多占27.5%，其次是生物/制药/化工/环保类占24.5%. What education can get in at ? 本科占比最多占75.8%，其次是大专占10.1%. High education required at ? 硕士占9.9%，博士占1.2%. Work experience required at ? 1-3年占比最多占31%，其次是5-10年占28.1%. Where are the job locations at ? 海口占比最多占60.6%，其次是厦门占12.8%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
